These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 7036155)
1. Early evaluation of Ia monoclonal antibodies in prolonging non-human primate skin allograft survival. Chatterjee SN; Billings R; Bernoco D; Terasaki P Proc Eur Dial Transplant Assoc; 1981; 18():362-6. PubMed ID: 7036155 [TBL] [Abstract][Full Text] [Related]
2. Treatment with anti-Ia and antiblast/monocyte monoclonal antibodies can prolong skin allograft survival in nonhuman primates. Chatterjee S; Bernoco D; Billing R Hybridoma; 1982; 1(4):369-77. PubMed ID: 6765322 [TBL] [Abstract][Full Text] [Related]
3. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice. Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869 [TBL] [Abstract][Full Text] [Related]
4. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier. Koch U; Choksi S; Marcucci L; Korngold R J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252 [TBL] [Abstract][Full Text] [Related]
6. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice. Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection. Felix NJ; de Serres S; Meyer AA; Ting JP J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017 [TBL] [Abstract][Full Text] [Related]
8. Use of human leukocyte-specific monoclonal antibodies for clinically immunophenotyping lymphocytes of rhesus monkeys. Reimann KA; Waite BC; Lee-Parritz DE; Lin W; Uchanska-Ziegler B; O'Connell MJ; Letvin NL Cytometry; 1994 Sep; 17(1):102-8. PubMed ID: 8001455 [TBL] [Abstract][Full Text] [Related]
9. T cell-specific monoclonal antibodies abrogate the blood transfusion effect on kidney allograft survival in rhesus monkeys. den Butter G; Jonker M; Nooij FJ; van Schilfgaarde R; van Es AA Transplant Proc; 1987 Feb; 19(1 Pt 2):1461-3. PubMed ID: 3274355 [No Abstract] [Full Text] [Related]
10. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms]. Hao J; Liu J; Xie S Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):593-6. PubMed ID: 11798930 [TBL] [Abstract][Full Text] [Related]
11. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model. Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564 [TBL] [Abstract][Full Text] [Related]
12. Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization. Wu GD; He Y; Chai NN; Toyoda M; Dunn R; Kehry MR; Klein AS; Jordan SC Transpl Immunol; 2008 Jul; 19(3-4):178-86. PubMed ID: 18595710 [TBL] [Abstract][Full Text] [Related]
13. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens. Halliday GM; Odling KA; Muller HK Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936 [TBL] [Abstract][Full Text] [Related]
14. Long-term limb allograft survival using a short course of anti-CD45RB monoclonal antibody, LF 15-0195, and rapamycin in a mouse model. Zhong T; Liu Y; Jiang J; Wang H; Temple CL; Sun H; Garcia B; Zhong R; Ross DC Transplantation; 2007 Dec; 84(12):1636-43. PubMed ID: 18165776 [TBL] [Abstract][Full Text] [Related]
15. Effects of CD4 and CD8 specific monoclonal antibodies in vitro and in vivo on T cells and their relation to the allograft response in rhesus monkeys. Jonker M; Nooij FJ; Steinhof G Transplant Proc; 1987 Oct; 19(5):4308-14. PubMed ID: 2445065 [No Abstract] [Full Text] [Related]
16. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice. Margenthaler JA; Landeros K; Kataoka M; Flye MW Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472 [TBL] [Abstract][Full Text] [Related]
17. 4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD40L monoclonal antibodies. Lee J; Lee EN; Kim EY; Lee HJ; Park HJ; Sun CL; Lee SK; Joh JW; Lee KW; Kwon GY; Kim SJ Transplant Proc; 2005; 37(1):123-5. PubMed ID: 15808569 [TBL] [Abstract][Full Text] [Related]
18. Role of CD4+ and CD8+ T cells in murine skin and heart allograft rejection across different antigenic desparities. Youssef AR; Otley C; Mathieson PW; Smith RM Transpl Immunol; 2004 Dec; 13(4):297-304. PubMed ID: 15589743 [TBL] [Abstract][Full Text] [Related]
19. Effect of ex vivo perfusion with anti-Ia monoclonal antibodies on rat cardiac allograft survival. Sone Y; Sakagami K; Orita K Transplant Proc; 1987 Feb; 19(1 Pt 1):599-604. PubMed ID: 3547831 [No Abstract] [Full Text] [Related]
20. The facilitating effect of one-DR antigen sharing in renal allograft tolerance induced by donor bone marrow in rhesus monkeys. Thomas JM; Verbanac KM; Smith JP; Kasten-Jolly J; Gross U; Rebellato LM; Haisch CE; Carver FM; Thomas FT Transplantation; 1995 Jan; 59(2):245-55. PubMed ID: 7839448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]